Elevance Health Pre-Tax Profit Margin 2010-2024 | ELV
Current and historical pre-tax profit margin for Elevance Health (ELV) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Elevance Health pre-tax profit margin for the three months ending June 30, 2024 was .
| Elevance Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-06-30 | $171.96B | $8.58B | 4.99% |
| 2024-03-31 | $171.75B | $8.04B | 4.68% |
| 2023-12-31 | $171.34B | $7.72B | 4.50% |
| 2023-09-30 | $168.62B | $7.76B | 4.60% |
| 2023-06-30 | $165.71B | $8.23B | 4.97% |
| 2023-03-31 | $160.67B | $7.91B | 4.92% |
| 2022-12-31 | $156.60B | $7.60B | 4.85% |
| 2022-09-30 | $153.25B | $8.03B | 5.24% |
| 2022-06-30 | $149.13B | $7.89B | 5.29% |
| 2022-03-31 | $144.35B | $8.13B | 5.63% |
| 2021-12-31 | $138.64B | $8.00B | 5.77% |
| 2021-09-30 | $133.88B | $7.14B | 5.33% |
| 2021-06-30 | $129.22B | $5.53B | 4.28% |
| 2021-03-31 | $124.63B | $6.33B | 5.07% |
| 2020-12-31 | $121.87B | $6.24B | 5.12% |
| 2020-09-30 | $117.45B | $6.73B | 5.73% |
| 2020-06-30 | $112.97B | $7.83B | 6.93% |
| 2020-03-31 | $109.17B | $6.13B | 5.61% |
| 2019-12-31 | $104.21B | $5.99B | 5.74% |
| 2019-09-30 | $100.18B | $5.43B | 5.42% |
| 2019-06-30 | $96.76B | $5.18B | 5.36% |
| 2019-03-31 | $94.23B | $5.23B | 5.55% |
| 2018-12-31 | $92.11B | $5.07B | 5.50% |
| 2018-09-30 | $91.41B | $4.65B | 5.09% |
| 2018-06-30 | $90.59B | $4.53B | 5.00% |
| 2018-03-31 | $90.05B | $4.23B | 4.70% |
| 2017-12-31 | $90.04B | $3.96B | 4.40% |
| 2017-09-30 | $89.07B | $4.50B | 5.05% |
| 2017-06-30 | $88.05B | $4.52B | 5.13% |
| 2017-03-31 | $87.10B | $4.76B | 5.46% |
| 2016-12-31 | $84.86B | $4.56B | 5.37% |
| 2016-09-30 | $83.34B | $4.27B | 5.12% |
| 2016-06-30 | $81.84B | $4.26B | 5.21% |
| 2016-03-31 | $80.40B | $4.37B | 5.44% |
| 2015-12-31 | $79.16B | $4.63B | 5.85% |
| 2015-09-30 | $77.95B | $5.14B | 6.60% |
| 2015-06-30 | $76.61B | $5.10B | 6.66% |
| 2015-03-31 | $75.07B | $4.81B | 6.40% |
| 2014-12-31 | $73.87B | $4.37B | 5.91% |
| 2014-09-30 | $72.79B | $3.95B | 5.43% |
| 2014-06-30 | $72.09B | $3.74B | 5.19% |
| 2014-03-31 | $71.31B | $3.69B | 5.17% |
| 2013-12-31 | $71.02B | $3.84B | 5.41% |
| 2013-09-30 | $68.44B | $3.85B | 5.62% |
| 2013-06-30 | $65.94B | $3.99B | 6.05% |
| 2013-03-31 | $63.66B | $3.83B | 6.02% |
| 2012-12-31 | $61.50B | $3.86B | 6.28% |
| 2012-09-30 | $61.49B | $3.86B | 6.28% |
| 2012-06-30 | $61.54B | $3.88B | 6.31% |
| 2012-03-31 | $61.23B | $3.84B | 6.27% |
| 2011-12-31 | $60.71B | $3.96B | 6.52% |
| 2011-09-30 | $60.02B | $4.23B | 7.05% |
| 2011-06-30 | $59.19B | $4.32B | 7.30% |
| 2011-03-31 | $58.52B | $4.45B | 7.60% |
| 2010-12-31 | $58.70B | $4.35B | 7.42% |
| 2010-09-30 | $63.03B | $7.94B | 12.60% |
| 2010-06-30 | $63.89B | $7.92B | 12.40% |
| 2010-03-31 | $64.87B | $7.85B | 12.09% |
| 2009-12-31 | $64.94B | $7.40B | 11.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $121.497B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $44.320B | 16.94 |
| ICON (ICLR) | Ireland | $23.561B | 21.17 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $17.560B | 26.63 |
| Natera (NTRA) | United States | $15.549B | 0.00 |
| Revvity (RVTY) | United States | $15.548B | 27.23 |
| Viatris (VTRS) | United States | $13.785B | 4.20 |
| CochLear (CHEOY) | Australia | $12.759B | 0.00 |
| Solventum (SOLV) | United States | $11.670B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.275B | 31.18 |
| Charles River Laboratories (CRL) | United States | $10.239B | 19.35 |
| Sonic Healthcare (SKHHY) | Australia | $9.066B | 0.00 |
| Doximity (DOCS) | United States | $7.965B | 50.47 |
| HealthEquity (HQY) | United States | $6.980B | 37.88 |
| Bausch + Lomb (BLCO) | Canada | $6.671B | 28.71 |
| PACS (PACS) | United States | $6.029B | 0.00 |
| Organon (OGN) | United States | $4.938B | 5.02 |
| Life Times (LTH) | United States | $4.827B | 40.35 |
| Sotera Health (SHC) | United States | $4.747B | 23.94 |
| Surgery Partners (SGRY) | United States | $4.058B | 44.96 |
| Concentras Parent (CON) | United States | $2.838B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.613B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.599B | 97.86 |
| BrightSpring Health Services (BTSG) | United States | $2.570B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.194B | 0.00 |
| Premier (PINC) | United States | $2.003B | 9.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.618B | 8.12 |
| CareDx (CDNA) | United States | $1.566B | 0.00 |
| Agilon Health (AGL) | United States | $1.539B | 0.00 |
| Progyny (PGNY) | United States | $1.517B | 26.67 |
| Teladoc Health (TDOC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.314B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.153B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Pediatrix Medical (MD) | United States | $0.967B | 10.52 |
| Embecta (EMBC) | United States | $0.817B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.466B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.346B | 13.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.248B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.34 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| Beauty Health (SKIN) | United States | $0.171B | 0.00 |
| MultiPlan (MPLN) | United States | $0.118B | 0.00 |
| Nutex Health (NUTX) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 22.49 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.087B | 0.00 |
| SBC Medicals (SBC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |